文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

成人呼吸衰竭与脓毒症体外膜氧合治疗的长期生存

Long-Term Survival in Adults Treated With Extracorporeal Membrane Oxygenation for Respiratory Failure and Sepsis.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论单中心回顾性队列显示,接受体外膜氧合治疗的成人呼吸衰竭与脓毒症患者出院生存率64%,存活至90天者5年生存率87%,感染性疾病患者尤为获益(88-100%)。

该单中心回顾性队列研究纳入1995年至2013年12月在Karolinska大学医院因呼吸衰竭和脓毒症接受体外膜氧合治疗的255例成人患者,通过国家死因登记获取生存状态,采用Kaplan-Meier法计算生存率。结果显示64%存活至出院,存活者中位随访4.4年,出院后最初数月死亡率高;存活至治疗后90天的患者5年生存率为87%,感染性疾病患者为88-100%。作者认为,体外膜氧合治疗在适当选择的成人呼吸衰竭与脓毒症患者中可挽救生命,存活最初数月者长期生存似乎良好,尤其是感染性疾病患者。

要点

  • 255例因呼吸衰竭和脓毒症接受体外膜氧合的成人中,64%存活至出院。
  • 存活至治疗后90天的患者5年生存率为87%,感染性疾病患者达88-100%。
  • 出院后最初数月死亡率高,晚期死亡见于多数诊断组,但Kaplan-Meier曲线随时间趋于平缓。
  • 存活者中位随访时间为4.4年。
  • 作者认为,体外膜氧合在适当选择的成人呼吸衰竭与脓毒症患者中可挽救生命,存活最初数月者长期生存似乎良好。

适用人群与场景

  • 1995年成人服务建立至2013年12月期间,在Karolinska大学医院因呼吸衰竭和脓毒症接受体外膜氧合治疗的成人患者。

研究设计与关键结果

  • 单中心回顾性队列研究,纳入255例因呼吸衰竭和脓毒症接受体外膜氧合的成人患者,64%存活至出院。
  • 存活者中位随访4.4年,出院后最初数月死亡率高。
  • 存活至治疗后90天的患者5年生存率为87%,感染性疾病患者为88-100%。
  • 晚期死亡见于多数诊断组,但Kaplan-Meier曲线随时间趋于平缓。

证据类型、等级与局限

  • 证据类型:单中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,体外膜氧合治疗在适当选择的成人呼吸衰竭与脓毒症患者中可挽救生命。
  • 作者认为,对体外膜氧合治疗后存活最初数月的患者,长期生存似乎良好,尤其是感染性疾病患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: The use of extracorporeal membrane oxygenation in adults with respiratory failure and sepsis is steadily increasing, but the knowledge on long-term survival in this group is scarce. The aim of the present study was to investigate the 5-year survival rates and causes of late death in this group of patients.

DESIGN: Single-center retrospective cohort study.

SETTING: Karolinska University Hospital, Stockholm, Sweden.

PATIENTS: Adult patients treated with extracorporeal membrane oxygenation for respiratory failure and sepsis between the service being established for adults in 1995 and December 2013.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Survival status was attained from a national Causes of Death registry. Minimal patient background data, along with data on survival and causes of death were collected. Survival rates were calculated using the Kaplan-Meier method. Of 255 subjects, 64% survived to discharge. The median follow-up time in survivors was 4.4 years. There was a high mortality rate within the first months after discharge. In the group of patients who survived the first 90 days after treatment, the 5-year survival rate was 87% and was particularly beneficial in patients treated for infectious diseases (88-100%). Late deaths were seen in most diagnostic groups, but the Kaplan-Meier curves flattened out over time.

CONCLUSIONS: Extracorporeal membrane oxygenation treatment in adult patients with respiratory failure and sepsis can be lifesaving in appropriately selected patients. For patients who survive the first months after extracorporeal membrane oxygenation treatment, long-term survival seems good, especially in patients treated for infections.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. von Bahr V, Hultman J, Eksborg S, et al. Long-Term Survival in Adults Treated With Extracorporeal Membrane Oxygenation for Respiratory Failure and Sepsis. Crit Care Med. 2017. PMID: 28098624. doi:10.1097/CCM.0000000000002078

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。